Note: Ingredients listed on restricted chemical lists
General Information
Version
3.2
Revision date
2024-07-18
Product name
Enclean
Emergency telephone
+44 1235 239670
Icons in SDS
Company Information
company name
Certis Belchim B.V.
e-mail address of the competent person responsible for the Safety Data Sheet
info.uk@certisbelchim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H412
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Harmful to aquatic life with long lasting effects. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P264 - Wash thoroughly after handling. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P273 - Avoid release to the environment. P501 - Dispose of contents and container in accordance with local regulation.
Supplemental label elements
EUH066 - Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %